Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
29
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
12
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Iovance Biotherapeutics
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Rising Interest Rates And Dilution Will Stifle TIL Progress
Key Takeaways Sustained high costs, complex distribution, and slow commercialization delay profitability and threaten market share amid rising competition from newer cancer therapies. Ongoing financial challenges, including exposure to interest rates and revenue pressure from drug pricing scrutiny, heighten risk of shareholder dilution and reduced margins.
View narrative
US$1.00
FV
169.0% overvalued
intrinsic discount
29.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Ryman Healthcare
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Rising Interest Rates And Policy Risks Will Hamper Aged Care
Key Takeaways Heightened exposure to interest rate risk, housing market cycles, and regulatory changes is constraining profitability, project pipeline, and earnings predictability. Demographic and labor trends, including declining resident wealth and rising workforce challenges, threaten sustained demand and drive up long-term operating costs.
View narrative
NZ$2.51
FV
1.2% undervalued
intrinsic discount
6.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Redwire
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Escalating Overruns Will Mar NASA Ties Yet Allow Cautious Recovery
Key Takeaways Persistent cost volatility, supply chain risks, and delayed commercialization create unstable revenues and ongoing pressures on margin improvement. Competitive threats and high leverage challenge Redwire's ability to achieve sustainable long-term growth and financial stability.
View narrative
US$10.00
FV
9.0% undervalued
intrinsic discount
47.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
KULR
KULR Technology Group
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Heavy Dilution And Bitcoin Volatility Will Hinder Growth But Electrification Trends Will Spur Recovery
Key Takeaways Heavy reliance on external capital and strategic bets like Bitcoin create earnings volatility and risk shareholder dilution, despite potential industry tailwinds. Intense competition, rapid standardization, and operational execution challenges threaten KULR's ability to scale higher-margin products and maintain sustained, profitable growth.
View narrative
US$12.00
FV
58.5% undervalued
intrinsic discount
73.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Cloudflare
AN
AnalystLowTarget
Consensus Narrative from 29 Analysts
Rising Cybersecurity Regulation And Hyperscaler Pressure Will Erode Margins
Key Takeaways Rising regulatory and geopolitical pressures are increasing Cloudflare's costs, limiting market expansion, and threatening long-term margin and earnings growth. Intensifying competition, open-source adoption, and sustainability mandates are eroding product differentiation, pricing power, and operational efficiency.
View narrative
US$116.43
FV
68.5% overvalued
intrinsic discount
24.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
CleanSpark
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Rising Regulatory Pressure Will Strain Bitcoin Mining Yet Offer Hope
Key Takeaways CleanSpark's growth and profitability are vulnerable to shifting regulations, volatile bitcoin markets, and technological disruptions that could undermine mining operations and asset values. Reliance on efficient energy use and aggressive expansion exposes the company to energy cost swings, integration challenges, and potential liquidity risks during prolonged market downturns.
View narrative
US$15.00
FV
34.5% undervalued
intrinsic discount
17.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Albemarle
AN
AnalystLowTarget
Consensus Narrative from 22 Analysts
Lithium Oversupply And Regulatory Pressures Will Erode Margins
Key Takeaways Advances in alternative battery technologies and global supply expansion threaten demand, pricing power, and predictability of Albemarle's revenue and earnings. Increasing regulatory, political, and environmental pressures risk higher compliance costs, operational uncertainty, and reduced profitability over time.
View narrative
US$58.00
FV
40.2% overvalued
intrinsic discount
4.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Tilray Brands
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Fragmented Legalization And Oversupply Will Hamper International Scaling
Key Takeaways Regulatory hurdles, shifting consumer trends, and integration issues are likely to limit Tilray's revenue growth and compress margins across international markets and core business lines. Dependence on U.S. legalization, oversupply risks, and elevated operating costs threaten the company's long-term growth prospects and earnings stability.
View narrative
US$0.60
FV
91.7% overvalued
intrinsic discount
4.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Zeta Global Holdings
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Digital Clutter And Tighter Privacy Rules Will Cripple Ad Targeting
Key Takeaways Expanding data privacy rules and reduced third-party data access threaten Zeta's core AI marketing offerings, client retention, and long-term growth prospects. Growing reliance on a small client base and unsustainable tech investments risk revenue volatility and margin compression as industry dynamics and customer expectations evolve.
View narrative
US$18.00
FV
8.6% overvalued
intrinsic discount
16.35%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies